title: Correlation between Charlson comorbidity index and outcome in patients with chronic phase chronic myeloid leukemia treated with second-generation tyrosine kinase inhibitors upfront.
authors.affiliation: Department of Cellular Biotechnologies and Hematology, Sapienza University , Rome , Italy.
authors.forename: Massimo
authors.initials: M
authors.lastname: Breccia
authors.forename: Matteo
authors.initials: M
authors.lastname: Molica
authors.forename: Gioia
authors.initials: G
authors.lastname: Colafigli
authors.forename: Irene
authors.initials: I
authors.lastname: Zacheo
authors.forename: Roberto
authors.initials: R
authors.lastname: Latagliata
authors.forename: Agostino
authors.initials: A
authors.lastname: Tafuri
authors.forename: Giuliana
authors.initials: G
authors.lastname: Alimena
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D015897:Comorbidity; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D015466:Leukemia, Myeloid, Chronic-Phase / Q000188:drug therapy* / Q000401:mortality* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D011379:Prognosis; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use*; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors*; D015996:Survival Rate; D055815:Young Adult
chemical_list: D047428:Protein Kinase Inhibitors; D011505:Protein-Tyrosine Kinases